Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells

[Image: see text] Doxorubicin (DOX) is a cornerstone chemotherapeutic agent for the treatment of several malignancies such as breast cancer; however, its activity is ameliorated by the development of a resistant phenotype. Phyllanthus species have been studied previously for their potential anticanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Sattar, Ola E., Allam, Rasha M., Al-Abd, Ahmed M., El-Halawany, Ali M., EL-Desoky, Ahmed M., Mohamed, Shanaz O., Sweilam, Sherouk Hussein, Khalid, Mohammad, Abdel-Sattar, Essam, Meselhy, Meselhy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413485/
https://www.ncbi.nlm.nih.gov/pubmed/37576627
http://dx.doi.org/10.1021/acsomega.3c02953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413485/
https://www.ncbi.nlm.nih.gov/pubmed/37576627
http://dx.doi.org/10.1021/acsomega.3c02953

Ejemplares similares